| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CLINICAL STUDY |
Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Hospital Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt am Main, Germany and 1 Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital Munich, Munich, Germany
(Correspondence should be addressed to K Badenhoop; Email: badenhoop{at}em.uni-frankfurt.de)
Background: Endocrine autoimmune disorders share genetic susceptibility loci, causing a disordered T-cell activation and homeostasis (HLA class II genes, CTLA-4). Recent studies showed a genetic variation within the PTPN22 gene to be an additional risk factor.
Materials and Methods: Patients with type 1 diabetes (n = 220), Hashimoto’s thyroiditis (n = 94), Addison’s disease (n = 121) and healthy controls (n = 239) were genotyped for the gene polymorphism PTPN22 1858 C/T.
Results: Our study confirms a significant association between allelic variation of the PTPN22 1858 C/T polymorphism and type 1 diabetes mellitus (T1D). 1858T was observed more frequently in T1D patients (19.3% vs 11.3%, P = 0.0009; odds ratio for allele T = 1.88, 95% confidence interval [1.3–2.7]). Furthermore, we found a strong association in female patients with T1D (P = 0.0003), whereas there was no significant difference between male patients with type 1 diabetes and male controls. No significant difference was observed between the distribution of PTPN22 C/T in patients with Hashimoto’s thyroiditis or Addison’s disease and healthy controls.
Conclusion: The PTPN22 polymorphism 1858 C/T may be involved in the pathogenesis of type 1 diabetes mellitus by a sex-specific mechanism that contributes to susceptibility in females.
This article has been cited by other articles:
|
|
 |
|
  M. Araki, D. Chung, S. Liu, D. B. Rainbow, G. Chamberlain, V. Garner, K. M. D. Hunter, L. Vijayakrishnan, L. B. Peterson, M. Oukka, et al. Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice J. Immunol., October 15, 2009; 183(8): 5146 - 5157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. B. Villano, A. K. Huber, D. A. Greenberg, B. K. Golden, E. Concepcion, and Y. Tomer Autoimmune Thyroiditis and Diabetes: Dissecting the Joint Genetic Susceptibility in a Large Cohort of Multiplex Families J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1458 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms Endocr. Rev., October 1, 2008; 29(6): 697 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chelala, S. Duchatelet, M.-L. Joffret, R. Bergholdt, D. Dubois-Laforgue, P. Ghandil, F. Pociot, S. Caillat-Zucman, J. Timsit, and C. Julier PTPN22 R620W Functional Variant in Type 1 Diabetes and Autoimmunity Related Traits Diabetes, February 1, 2007; 56(2): 522 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, G. G. Song, S. K. Nath, and J. B. Harley The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis Rheumatology, January 1, 2007; 46(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Onengut-Gumuscu, J. H. Buckner, and P. Concannon A Haplotype-Based Analysis of the PTPN22 Locus in Type 1 Diabetes. Diabetes, October 1, 2006; 55(10): 2883 - 2889. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
